Atlas Venture Life Science Advisors, LLC Vigil Neuroscience, Inc. Transaction History
Atlas Venture Life Science Advisors, LLC
- $455 Million
- Q2 2025
A detailed history of Atlas Venture Life Science Advisors, LLC transactions in Vigil Neuroscience, Inc. stock. As of the latest transaction made, Atlas Venture Life Science Advisors, LLC holds 5,836,874 shares of VIGL stock, worth $47 Million. This represents 10.21% of its overall portfolio holdings.
Number of Shares
5,836,874
Previous 5,836,874
-0.0%
Holding current value
$47 Million
Previous $10.4 Million
346.66%
% of portfolio
10.21%
Previous 3.04%
Shares
1 transactions
Others Institutions Holding VIGL
# of Institutions
79Shares Held
38MCall Options Held
0Put Options Held
0-
Beryl Capital Management LLC Redondo Beach, CA4.61MShares$37.1 Million5.55% of portfolio
-
Northpond Ventures, LLC4.21MShares$33.9 Million51.65% of portfolio
-
Glazer Capital, LLC New York, NY3.01MShares$24.2 Million0.86% of portfolio
-
Oddo Bhf Asset Management Sas Paris, I02.3MShares$18.5 Million0.72% of portfolio
-
Ensign Peak Advisors, Inc Salt Lake City, UT1.58MShares$12.7 Million0.01% of portfolio
About Vigil Neuroscience, Inc.
- Ticker VIGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,268,600
- Market Cap $228M
- Description
- Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...